These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19593171)

  • 21. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia.
    Brower KJ; Myra Kim H; Strobbe S; Karam-Hage MA; Consens F; Zucker RA
    Alcohol Clin Exp Res; 2008 Aug; 32(8):1429-38. PubMed ID: 18540923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The analgesic effect of gabapentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study.
    Türe H; Sayin M; Karlikaya G; Bingol CA; Aykac B; Türe U
    Anesth Analg; 2009 Nov; 109(5):1625-31. PubMed ID: 19713257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients.
    Hanna M; O'Brien C; Wilson MC
    Eur J Pain; 2008 Aug; 12(6):804-13. PubMed ID: 18262450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
    Huang MC; Chen CH; Pan CH; Lin SK
    J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial.
    Reoux JP; Saxon AJ; Malte CA; Baer JS; Sloan KL
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1324-9. PubMed ID: 11584152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gabapentin withdrawal syndrome in a post-liver transplant patient.
    Finch CK; Eason J; Usery JB
    J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):236-8. PubMed ID: 20718643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Akathisia induced by gabapentin withdrawal.
    See S; Hendriks E; Hsiung L
    Ann Pharmacother; 2011 Jun; 45(6):e31. PubMed ID: 21652784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose benzodiazepine dependence: description of 29 patients treated with flumazenil infusion and stabilised with clonazepam.
    Quaglio G; Pattaro C; Gerra G; Mathewson S; Verbanck P; Des Jarlais DC; Lugoboni F
    Psychiatry Res; 2012 Aug; 198(3):457-62. PubMed ID: 22424905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
    Parsons B; Tive L; Huang S
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
    Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
    J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative administration of gabapentin for shoulder arthroscopy: a prospective, randomized, double-blind, placebo-controlled study.
    Spence D; Goff J; Mohan E; Bowen K; Osborne L; Maye J
    AANA J; 2011 Aug; 79(4 Suppl):S43-50. PubMed ID: 22403966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM; Canafax DM; Cundy KC
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gabapentin combined with naltrexone for the treatment of alcohol dependence.
    Anton RF; Myrick H; Wright TM; Latham PK; Baros AM; Waid LR; Randall PK
    Am J Psychiatry; 2011 Jul; 168(7):709-17. PubMed ID: 21454917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
    Mancino MJ; McGaugh J; Chopra MP; Guise JB; Cargile C; Williams DK; Thostenson J; Kosten TR; Sanders N; Oliveto A
    J Clin Psychopharmacol; 2014 Apr; 34(2):234-9. PubMed ID: 24525654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients.
    González G; Desai R; Sofuoglu M; Poling J; Oliveto A; Gonsai K; Kosten TR
    Drug Alcohol Depend; 2007 Feb; 87(1):1-9. PubMed ID: 16930857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of gabapentin dose in treatment of opioid withdrawal.
    Salehi M; Kheirabadi GR; Maracy MR; Ranjkesh M
    J Clin Psychopharmacol; 2011 Oct; 31(5):593-6. PubMed ID: 21869694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe protracted alcohol withdrawal syndrome: prevalence and pharmacological treatment at an inpatient detoxification unit--a naturalistic study.
    Bonnet U; Specka M; Hamzavi Abedi R; Wiltfang J; Scherbaum N
    Pharmacopsychiatry; 2009 Mar; 42(2):76-8. PubMed ID: 19308884
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.